Radical scavenging activity of bisbenzylisoquinoline alkaloids and traditional prophylactics against chemotherapy-induced oral mucositis

Journal of Clinical Pharmacy and Therapeutics

Volumn 34, Issue 2, 2009, Pages 197-205

  Kaji, H ^a   Inukai, Y ^a   Maiguma, T ^a   Ono, H ^a   Teshima, D ^a   Hiramoto, K ^a   Makino, K ^a  

^a SHUJITSU UNIVERSITY   (Japan)

Author keywords

Allopurinol; Bisbenzylisoquinoline alkaloids; Chemotherapy; Electron spin resonance; Oral mucositis; Radical

Indexed keywords

1,1 DIPHENYL 2 PICRYLHYDRAZYL; 2,2' AZINOBIS(3 ETHYLBENZOTHIAZOLINE 6 SULFONIC ACID); ALLOPURINOL; BERBAMINE; BISBENZYLISOQUINOLINE ALKALOID; CAMOSTAT MESILATE; CEPHARANTHINE; CYCLEANINE; FLUOROURACIL; GABEXATE MESILATE; HYDROQUINONE; HYDROXYL RADICAL; ISOTETRANDRINE; MELATONIN; MOUTHWASH; SCAVENGER; SUPEROXIDE;

ANTIOXIDANT ACTIVITY; ARTICLE; DOSE RESPONSE; DRUG ACTIVITY; DRUG MECHANISM; DRUG METABOLISM; DRUG SCREENING; DRUG STRUCTURE; HUMAN; ORAL MUCOSAL DISEASE; PROPHYLAXIS;

ALLOPURINOL; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; BENZOTHIAZOLES; BENZYLISOQUINOLINES; BIPHENYL COMPOUNDS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRON SPIN RESONANCE SPECTROSCOPY; FREE RADICAL SCAVENGERS; HYDROXYL RADICAL; MUCOSITIS; OXIDANTS; PICRATES; REACTIVE OXYGEN SPECIES; STRUCTURE-ACTIVITY RELATIONSHIP; SULFONIC ACIDS;

EID: 61349096653     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2008.00993.x     Document Type: Article

References (43)

1. Plevova P (1999) Prevention and treatment of chemotherapy and radiotherapy-induced oral mucositis: a review. Oral Oncolgy, 35, 453 470.
2. Sharma R, Tobin P, Clarke SJ (2005) Management of chemotherapy-induced nausea, vomiting, oral mucositis, and diarrhoea. Lancet Oncology, 6, 93 102.
3. Schwartz PM, Dunigan JM, Marsh JC, Handschumacher RE (1980) Allopurinol modification of the toxicity and antitumor activity of 5-fluorouracil. Cancer Research, 40, 1885 1889.
4. Howell SB, Wung WE, Taetle R, Hussain F, Romine JS (1981) Modulation of 5-fluorouracil toxicity by allopurinol in man. Cancer, 48, 1281 1289.
5. Sato S, Iwaizumi M, Handa K, Tamura Y (1977) Electron spin resonance study on the mode of generation of free radicals of daunomycin, adriamycin, and carboquone in NAD(P)H-microsome system. Gann, 68, 603 608.
6. Miura T, Muraoka S, Ogiso T (1991) Generation of adriamycin radical by interaction of adriamycin with serum. Research Communications in Chemical Pathology and Pharmacology, 71, 115 124.
7. Van Maanen JM, De Ruiter C, Kootstra PR, De Vries J, Pinedo HM (1986) Free radical formation from the antineoplastic agent VP 16-213. Free Radical Research Communications, 1, 263 272.
8. Yoshida M, Fukuda A, Hara M, Terada A, Kitanaka Y, Owada S (2003) Melatonin prevents the increase in hydroxyl radical-spin trap adduct formation caused by the addition of cisplatin in vitro. Life Sciences, 72, 1773 1780.
9. Bekerecioglu M, Kutluhan A, Demirtas I, Karaayvaz M (1998) Prevention of adriamycin-induced skin necrosis with various free radical scavengers. Journal of Surgical Research, 15, 61 65.
10. Kocak G, Erbil KM, Ozdemir I, Aydemir S, Sunar B, Tuncel M, Atalay S (2003) The protective effect of melatonin on adriamycin-induced acute cardiac injury. Canadian Journal of Cardiology, 19, 535 541.
11. Baliga R, Zhang Z, Baliga M, Ueda N, Shah SV (1998) In vitro and in vivo evidence suggesting a role for iron in cisplatin-induced nephrotoxicity. Kidney International, 53, 394 401.
12. Teranishi M, Nakashima T, Wakabayashi T (2001) Effects of alpha-tocopherol on cisplatin-induced ototoxicity in guinea pigs. Hearing Research, 151, 61 70.
13. Alberts DS, Noel JK (1995) Cisplatin-associated neurotoxicity: can it be prevented? Anti-Cancer Drugs, 6, 369 383.
14. Yasuda T, Chiba H, Satomi T, Matsuo A, Kaneko T, Miyamatsu H (2008) A pilot study of rebamipide-gargle for chemoradiotherapy-induced mucositis in oral cancer patients. Gan To Kagaku Ryoho, 35, 1157 1161.
15. Furusawa S, Wu J (2007) The effects of biscoclaurine alkaloid cepharanthine on mammalian cells: implications for cancer, shock, and inflammatory diseases. Life Sciences, 80, 1073 1079.
16. Augustin AJ, Böker T, Blumenröder SH, Lutz J, Spitznas M (1994) Free radical scavenging and antioxidant activity of allopurinol and oxypurinol in experimental lens-induced uveitis. Investigative Ophthalmology & Visual Science, 35, 3897 3904.
17. Terasaka H, Machino M, Saito M, Fujisawa S, Satoh K, Jiang Y, Sakagami H (2002) Re-evaluation of antitumor activity of cepharanthin. Anticancer Research, 22, 165 170.
18. Takebayashi J, Tai A, Yamamoto I (2002) Long-term radical scavenging activity of AA-2G and 6-acyl-AA-2G against 1,1-diphenyl-2-picrylhydrazyl. Biological & Phrarmaceutical Bulletin, 25, 1503 1505.
19. Fujinami Y, Tai A, Yamamoto I (2001) Radical scavenging activity against 1,1-diphenyl-2-picrylhydrazyl of ascorbic acid 2-glucoside (AA-2G) and 6-acyl-AA-2G. Chemical & Phrarmaceutical Bulletin, 49, 642 644.
20. Takebayashi J, Tai A, Yamamoto I (2003) pH-dependent long-term radical scavenging activity of AA-2G and 6-Octa-AA-2G against 2,2′-azinobis(3- ethylbenzothiazoline-6-sulfonic acid) radical cation. Biological & Phrarmaceutical Bulletin, 26, 1368 1370.
21. Kogure K, Tsuchiya K, Abe K, Akasu M, Tamaki T, Fukuzawa K, Terada H (2003) Direct radical scavenging by the bisbenzylisoquinoline alkaloid cepharanthine. Biochimica et Biophysica Acta, 1622, 1 5.
22. Nakamura K, Natsugoe S, Kumanohoso T et al. (1996) Prophylactic action of allopurinol against chemotherapy-induced stomatitis - inhibition of superoxide dismutase and proteases. Anti-Cancer Drugs, 7, 235 239.
23. Houghton JA, Houghton PJ (1983) Elucidation of pathways of 5-fluorouracil metabolism in xenografts of human colorectal adenocarcinoma. European Journal of Cancer and Clinnical Oncology, 19, 807 815.
24. Davis CA, Nick HS, Agarwal A (2001) Manganese superoxide dismutase attenuates cisplatin-induced renal injury: importance of superoxide. Journal of American Society Nephrology, 12, 2683 2690.
25. Herrstedt J (2000) Prevention and management of mucositis in patients with cancer. International Journal of Antimicrobial Agents, 16, 161 163.
26. Yoshida M, Wakabayashi G, Ishikawa H et al. (2003) A possible defensive mechanism in the basal region of gastric mucosa and the healing of erosions. Clinical Hemorheology Microcirculation, 29, 301 312.
27. Yoon WH, Jung YJ, Kim TD et al. (2004) Gabexate mesilate inhibits colon cancer growth, invasion, and metastasis by reducing matrix metalloproteinases and angiogenesis. Clinical Cancer Research, 10, 4517 4526.
28. Menke HE, Dekker SK, Noordhoek Hegt V, Pavel S, Westerhof W (1992) Exogenous ochronosis, a little-known side effect of hydroquinone-containing ointments. Nederlands Tijdschrift Voor Geneeskunde, 136, 187 190.
29. Matsubayashi T, Sakaeda T, Kita T et al. (2003) Intradermal concentration of hydroquinone after application of hydroquinone ointments is higher than its cytotoxic concentration. Biological & Pharmaceutical Bulletin, 26, 1365 1367.
30. Imai K, Inagaki M, Saitoh Y, Yura A, Sakagami H, Suzuki M, Oguchi K (2002) Radical scavenging activity and cytotoxicity of phenethyl ether and cinnamic amide derivatives. Anticancer Research, 22, 1661 1666.
31. Gaskell M, McLuckie I, Farmer PB (2004) Comparison of the mutagenic activity of the benzene metabolites, hydroquinone and para-benzoquinone in the supF forward mutation assay: a role for minor DNA adducts formed from hydroquinone in benzene mutagenicity. Mutation Research, 554, 387 398.
32. Nakamura K, Tsuchiya S, Sugimoto Y, Sugimura Y, Yamada Y (1992) Histamine release inhibition activity of bisbenzylisoquinoline alkaloids. Planta Medica, 58, 505 508.
33. Sato T, Ohnishi ST (1982) In vitro anti-sickling effect on cepharanthine. European Journal of Pharmacology, 83, 91 95.
34. Watanabe S (1984) Inhibition of platelet aggregation by cepharanthine is accomplished during the early, membrane-related activation process. Acta Medica Okayama, 38, 101 115.
35. Hotta T, Tanimura H, Yamaue H et al. (1997) Modulation of multidrug resistance by cepharanthine in fresh human gastrointestinal tumor cells. Oncology, 54, 153 157.
36. Harada K, Bando T, Yoshida H, Sato M (2001) Characteristics of antitumour activity of cepharanthin against a human adenosquamous cell carcinoma cell line. Oral Oncology, 37, 643 651.
37. Okamoto M, Ono M, Baba M (2001) Suppression of cytokine production and neural cell death by the anti-inflammatory alkaloid cepharanthine: a potential agent against HIV-1 encephalopathy. Biochemical Pharmacology, 62, 747 753.
38. Wu J, Suzuki H, Zhou YW et al. (2001) Cepharanthine activates caspases and induces apoptosis in Jurkat and K562 human leukemia cell lines. Journal of Cellular Biochemistry, 82, 200 214.
39. Shiraishi N, Arima T, Aono K, Inouye B, Morimoto Y, Utsumi K (1980) Inhibition by biscoclaurine alkaloid of lipid peroxidation in biological membranes. Physiological Chemistry and Physics, 12, 299 305.
40. Aono K, Shiraishi N, Arita T, Inouye B, Nakazawa T, Utsumi K (1981) Changes in mitochondrial function by lipid peroxidation and their inhibition by biscoclaurin alkaloid. Physiological Chemistry and Physics, 13, 137 144.
41. Janero DR, Burghardt B (1989) Prevention of oxidative injury to cardiac phospholipid by membrane-active "stabilizing agents". Research Communications in Chemical Pathology and Pharmacology, 63, 163 173.
42. Kogure K, Goto S, Abe K, Ohiwa C, Akasu M, Terada H (1999) Potent antiperoxidation activity of the bisbenzylisoquinoline alkaloid cepharanthine: the amine moiety is responsible for its pH-dependent radical scavenge activity. Biochimica et Biophysica Acta, 1426, 133 142.
43. Srinivasan P, Vadhanam MV, Arif JM, Gupta RC (2002) A rapid screening assay for antioxidant potential of natural and synthetic agents in vitro. International Journal of Oncology, 20, 983 986.